Defence Research and Development Organisation (DRDO) on Tuesday released usage directions for consuming the 2DG medicine. The guidelines are approved by the Drugs Controller General of India (DCGI). 2DG is a prescription drug that was recently approved for emergency use.
These guidelines contain information about 2DG medicine such as its effectiveness, persons or groups who shouldn’t consume this drug, the correct duration for which the drug can be prescribed, and the means to procure the medicine.
Here are the directions to consume them, and things to keep in mind.
1. 2DG should be prescribed early on by the doctors. This drug can be prescribed for up to 10 days and the recipients can be both moderate to severe COVID patients.
2. This drug is approved for ‘Emergency Use’, and can be used as an adjunct therapy alongside the standard procedure followed in the treatment of a Covid patient.
3. 2DG has not yet been tested on patients with uncontrolled diabetes, severe cardiac problems, ARDS, severe hepatic and renal impairment. Hence, extra caution needs to be maintained.
4. Lactating and pregnant women should not be prescribed with 2DG, and the same applies to people below the age of 18.
5. Patients/Attendants looking to procure 2DG medicine should email their requirement to [email protected]. The email ID is of Dr. Reddy’s Lab, Hyderabad.
2-deoxy-D-glucose or ‘2-DG’ was cleared by DCGI on May 1 for emergency use as an adjunct therapy in moderate to severe Covid-19 patients. Later, Defence Minister Rajnath Singh and Health Minister Dr Harsh Vardhan had on May 17 released the first batch of the indigenously developed anti-Covid-19 drug.
2-DG has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab affiliated to the DRDO.